MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Team approach boosts weight loss in fatty liver disease
Disease control CompletedThis study tested whether combining liver care, diet advice, and psychological support helps people with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) lose weight and lower their risk of heart problems. 286 adults aged 40-79 took part. The goal was to see if mo…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated May 17, 2026 08:55 UTC
-
Probiotics show promise for fatty liver in early trial
Disease control CompletedThis study tested whether three types of probiotics could improve liver health in people with non-alcoholic fatty liver disease. 89 adults took probiotic capsules or a placebo daily for 8 weeks, along with a standard liver medication. Researchers measured changes in liver enzymes…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Chuncheon Sacred Heart Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Mineral water shows promise for fatty liver
Disease control CompletedThis study looked at whether drinking a mineral water rich in bicarbonate, sulfate, calcium, and magnesium could help people with a type of fatty liver disease called MASLD. 87 adults with MASLD were split into two groups: one drank the mineral water daily for 12 months plus foll…
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
Hidden liver epidemic: study reveals silent fatty liver disease in turkey
Knowledge-focused CompletedThis study measured how common Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is among 459 adults in Turkey who are overweight, have diabetes, or other risk factors. Participants had a quick liver scan and provided lifestyle and blood data. The goal was to find …
Matched conditions: MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC